EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

Binayak Rimal iD, Danielle A Nicklas, Chandra M Panthi, Christopher K Lippincott, Daniel C Belz, Elisa H Ignatius iD, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane iD

mSphere · 2023

DOI: 10.1128/msphere.00665-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2023. Verfasst von Binayak Rimal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Cystic Fibrosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Paratek Pharmaceuticals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

M. abscessus disease incidence is increasing in the United States. This disease is difficult to cure with existing antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusCystic FibrosisAnimalsMiceLinezolidCefoxitinMicrobial Sensitivity TestsAnti-Bacterial AgentsTetracyclinesImipenemRifabutinThienamycins

Stichwörter der Autor:innen

Mycobacterium abscessusMycobacteroides abscessusamikacinazithromycinbedaquilinebiapenemcefoxitinclofazimineimipenemlinezolidomadacyclinerifabutin

Substanzen

LinezolidCefoxitinAnti-Bacterial AgentsTetracyclinesImipenemRifabutinbiapenemThienamycinsomadacycline

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Center for Nontuberculous Mycobacteria and Bronchiectasis, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania, USA.

ORCID-Profile: Binayak Rimal, Elisa H Ignatius, Gyanu Lamichhane

Förderung

  • NIAID NIH HHS
  • Paratek Pharmaceuticals, Inc.

Zitieren

APA

Rimal, B., Nicklas, D. A., Panthi, C. M., Lippincott, C. K., Belz, D. C., Ignatius, E. H., Deck, D. H., Serio, A. W., & Lamichhane, G. (2023). Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease. mSphere. https://doi.org/10.1128/msphere.00665-22

Vancouver

Rimal B, Nicklas DA, Panthi CM, Lippincott CK, Belz DC, Ignatius EH, et al. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease. mSphere. 2023. doi:10.1128/msphere.00665-22

BibTeX
@article{Rimal2023,
  author = {Rimal, Binayak and Nicklas, Danielle A and Panthi, Chandra M and Lippincott, Christopher K and Belz, Daniel C and Ignatius, Elisa H and Deck, Daniel H and Serio, Alisa W and Lamichhane, Gyanu},
  title = {Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease},
  journal = {mSphere},
  year = {2023},
  doi = {10.1128/msphere.00665-22}
}
Kostenlos starten →